Absorption, distribution, metabolism continued

The drug discovery and development processes are time consuming and costly endeavors. It has been reported that on average it takes 10 to 15 years and costs more than 800 million to bring a molecule from discovery to market.12 Compounds fail for various reasons. One that accounts for a reported 40% of failures in clinical trials is poor pharmacokinetics.3 In an effort to improve the number of compounds that exhibit optimal absorption, distribution, metabolism, elimination (ADME), and pharmacokinetic (PK) properties and reach development, drug metabolism and pharmacokinetic scientists continually implement new technologies and compound screening approaches. 

Toxicokinetics studies are designed to measure the amount and rate of the absorption, distribution, metabolism, and excretion of a xenobiotic. These data are used to construct predictive mathematical models so that the distribution and excretion of other doses can be simulated. Such studies are carried out using radiolabeled compounds to facilitate measurement and total recovery of the administered dose. This can be done entirely in vivo by measuring levels in blood, expired air, feces, and urine these procedures can be done relatively noninvasively and continuously in the same animal. Tissue levels can be measured by sequential killing and analysis of organ levels. It is important to measure not only the compound administered but also its metabolites, because simple radioactivity counting does not differentiate among them. 

Klon et al., Journal of Chemical Information and Modeling, 2006 [49] Improved nave Bayesian modeling of numerical data for absorption, distribution, metabolism and excretion (ADME) property prediction 264 Nave Bayes with continuous numerical 81% 2D and 3D descriptors from Dragon (n = 3)... 

In vitro biochemical studies of drug metabolism, particularly studies associated with pharmacokinetic (PK) properties and potential toxicological consequences, are essential in drug discovery and development. For over a decade, the major pharmaceutical companies have been promoting such efforts for incorporation into early stages in discovery (Obach, 2001 Smith and van de Waterbeemd, 1999). Consequently, the failure rate of new chemical entities (NCEs) due to absorption, distribution, metabolism, and excretion (ADME) shortcomings in clinical trials, in contrast to some of the other major hurdles including poor efficacy and intolerable toxicity, has continuously decreased (Apic et ah, 2005). 

When a person is alive, blood is continually pumped through and around the body by the heart when a drug is administered, it will be absorbed into the bloodstream (the route by which this occurs ultimately depends upon the route of administration). The body processes this drug through a process known as ADME (absorption, distribution, metabolism, and elimination). 

Absorption, Distribution, Metabolism, Excretion (ADME). Absorption, distribution, metabolism, and excretion are factors critical to toxicity. They are often described by the sciences of toxicokinetics (what the body dose to the chemical) and toxicodynamics (what the chemical does to the body). Although each process is summarized separately below, it must be remembered that each factor influences the others in a continuous process of feedback and response. 

Drug therapy is a dynamic process. When a drug product is administered, absorption usually proceeds over a finite time interval, and distribution, metabolism, and excretion (ADME) of the drug and its metabolites proceed continuously at various rates. The relative rates of these ADME processes determine the time course of the drug in the body, most importantly at the receptor sites that are responsible for the pharmacological action of the drug. 

A review of the absorption, distribution and metabolism of PBBs in animals—mainly cattle and rodents—is already extant and will not be covered here (See DiCarlo et al, ref. 155). Suffice it to say that excretion rates of PBBs are exceedingly low, hence their biological half-lives long. Continued exposure leads to the build-up of PBBs in body fats. A major excretion route is via the lipid fraction of breast milk. 

Sources, Production, Important Compounds, Uses, Waste Products and Recycling, 4) Distribution in the Environment, in Foods and Living Orgamsms, 5) Uptake, Absorption, Transport and Distribution, Metabolism and Elimination in Plants, Animals and Humans, 6) Effects (beneficial and/or adverse) on Plants, Animals and Humans, 7) Hazard Evaluation and Limiting Concentrations, 8) Complete References using the Harvard (Name and Date) System. The reference citation system, regrettably not continuously found in the 1st edition, has been, as far as possible, followed in this edition for the benefit of our readers. 

Following absorption, chlordane rapidly leaves the blood for initial distribution to the liver and kidneys, followed by redistribution to adipose tissue (Ewing et al. 1985 Ohno et al. 1986). Once chlordane has been absorbed, little can be done to reduce the body burden (Ellenhorn and Barceloux 1988 Haddad and Winchester 1990 Rumack and Lovejoy 1991). Diuresis is not likely to be effective because of the high lipophilicity of chlordane. Dialysis and hemoperfusion are not expected to be practical because of the rapidity with which chlordane leaves the blood and locates in peripheral compartments, suggesting that chlordane has a large apparent volume of distribution. However, continued dosing with charcoal and cholestyramine may be useful to prevent reabsorption following biliary excretion. The barbiturates, which have been used to control poison-induced convulsions, may hasten metabolism and elimination of chlordane (Smith 1991). 

Upon absorption, the plasma concentration of the drug continues to rise until it reaches the maximum concentration. Cmax. At Cmax, the rates of elimination processes such as metabolism and excretion, which also begin to operate on the drug as soon as it enters the body, equal the rate at which it is absorbed (Fig. 3.1). Throughout the absorption process, the drug rapidly distributes to the red blood cells, organs, and all intra- and extracellular... 

As biological systems are dynamic, the concentration gradient will normally be maintained and an equilibrium will not be reached. Thus, the concentration on the inside of the membrane will be continuously decreasing as a result of ionization (see below), metabolism (see chap. 4), and removal by distribution into other compartments such as via blood flow (Fig. 3.4). It follows from Fick s Law that because A the surface area is an important term in the equation, the surface area of the site of exposure will have a major effect on the absorption of chemicals. 

---